Health Care Analysis

, Volume 10, Issue 3, pp 261–275 | Cite as

Evidence-Based Medicine as an Instrument for Rational Health Policy

  • Nikola Biller-Andorno
  • Reidar K. Lie
  • Ruud ter Meulen
Article

Abstract

This article tries to present a broad view on the values and ethicalissues that are at stake in efforts to rationalize health policy on thebasis of economic evaluations (like cost-effectiveness analysis) andrandomly controlled clinical trials. Though such a rationalization isgenerally seen as an objective and `value free' process, moral valuesoften play a hidden role, not only in the production of `evidence', butalso in the way this evidence is used in policy making. For example, thedefinition of effectiveness of medical treatment or health care serviceis heavily dependent on dominant individual or social views about thegoals of the particular treatment or service. There is also a concernthat a reliance on EBM in health policy will occur at the expense ofwidely shared social values like equity and solidarity. Moreover, thereis a concern that when economic considerations and rational proceduresbecome more influential, various `outside' groups third parties likeinsurance companies and policy makers will get a stronger influence onmedical practice which may lead to a change in the patient-providerrelationship. The authors conclude that social values and patientpreference should be explicitly addressed when health policy making isbased on economic and other scientific evidence.

Evidence-Based Medicine instrument rational health policy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anand, S. and Hanson, K. (1995) Disability Adjusted Life Years: A Critical Review. Cambridge, MA: Center for Population and Development Studies.Google Scholar
  2. Berg, M., Ter Meulen, R. and Van den Burg, M. (2001) Guidelines for Appropriate Care: The Importance of Normative Analysis. Health Care Analysis 9, 77–99.Google Scholar
  3. Biller-Andorno, N. (2001) Evidenz-basierte Gesundheitsversorgung–kritische Nachfragen vor medizinethischem Hintergrund (Evidence Based Health Care–Critical Inquiries from a Medico-Ethical Background). Wiener Medizinische Wochenschrift 152, 161–164.Google Scholar
  4. Biller-Andorno, N. and Karageorgiou, A. (2001) Country Report on Evidence Based Medicine in Germany. Paper presented at the EVIBASE State-of-the-Art Workshop Maastricht, February.Google Scholar
  5. Dickenson, D. (1999) Can Medical Criteria Settle Priority-Setting Debates? The Need for Ethical Analysis. Health Care Analysis 7, 131–137.Google Scholar
  6. Dickenson, D. and Ashcroft, R. (2001) Country Report Great Britain. Paper presented at the EVIBASE State-of-the-Art Workshop Maastricht, February.Google Scholar
  7. Dickenson, D. and Vineis, P. (2002) Evidence-Based Medicine and Quality of Care. This volume.Google Scholar
  8. Ernst, E. (2000) Komplementaermedizin–populaer und heftig umstritten. Gibt es “Charte Daten” fuer die Praxis? (Complementary Medicine–Popular and Controversial. Are There “Solid Data” for General Practice?). Muenchner Medizinische Wochenschrift 142(18), 38.Google Scholar
  9. Ham, C. (1999) Tragic Choices in Health Care: Lessons from the Child B Case. British Medical Journal 319, 1258–1261.Google Scholar
  10. Harris, J. (1987) QALYfying the Value of Life. Journal of Medical Ethics 13, 117–123.Google Scholar
  11. Harris, J. (1988) More and Better Justice. In J.M. Bell and S. Mendus (Eds.), Philosophy and Medical Welfare. Cambridge: Cambridge University Press.Google Scholar
  12. Hart, J.T. (1997) What Evidence Do We Need for Evidence Based Medicine. Journal of Epidemiology and Community Health 51, 23–99.Google Scholar
  13. Hope, T. (1995), Evidence Based Medicine and Ethics. Journal of Medical Ethics 21, 259–260.Google Scholar
  14. Lauterbach, K.W. (1998) Chancen und Grenzen von Leitlinien in der Medizin (Possibilities and Limits of Guidelines in Medicine). Zeitschrift fuer aerztliche Fortbildung und Qualitaetssicherung 92(2),99–105.Google Scholar
  15. Lie, R. (2001) Country Report on Evidence Based Medicine in Norway. Paper presented at the EVIBASE State-of-the-Art Workshop Maastricht, February.Google Scholar
  16. Meulen, R. ter and Made, J. van der (2000) The Extent and Limits of Solidarity in Dutch Health Care. International Journal of Social Welfare 9(4), 250–260.Google Scholar
  17. Meulen, R. ter and Van den Burg, M. (1999) Evidence-based medicine en de solidariteit tussen generaties. In J.J.M. van Delden, C.M.P.M. Hertogh and H.A.M. Manschot (Eds.), Morele problemen in de ouderenzorg.Google Scholar
  18. Morreim, E.H. (1986) Computing the Quality of Life. In G. Agich and C. Begley (Eds.), The Price of Health. Dordrecht: D. Reidel Publishing Company.Google Scholar
  19. Morrow, R.H. and Bryant, J.H. (1994) Measuring and Valuing Human Life: Cost-Effectiveness, Equity and Other Ethics-Based Issues. In Z. Bankowski and J.H. Bryant (Eds.), Poverty, Vulnerability, the Value of Human Life, an the Emergence of Bioethics. Geneva: CIOMS.Google Scholar
  20. Morrow, R.H. and Bryant, J.H. (1995) Health Policy Approaches to Measuring and Valuing Human Life: Conceptual and Ethical Issues. American Journal of Public Health 85, 1356–1360.Google Scholar
  21. Murray, C.J.L. (1996) Rethinking DALYs. In J.L.C. Murray and A.D. Lopez (Eds.), The Global Burden of Disease. Cambridge, MA: Harvard University Press.Google Scholar
  22. Nord, E. (1995) The Person-Trade-Off Approach to Valuing Health Care Programs. Medical Decision Making 15, 201–208.Google Scholar
  23. Nord, E. (2000) My Goodness–and Yours. A History, and Some Possible Futures, of Concerns for Fairness and Equity in DALYs. Unpublished paper.Google Scholar
  24. Norheim, O.F. (1999) Healthcare Rationing: Are Additional Criteria Needed for Assessing Evidence Based Clinical Practice Guidelines? British Medical Journal 319, 1426–1429.Google Scholar
  25. Nunes, R., Rego, G. and Serrao, D. (2001) Ethical Issues of Evidence Based Practice in Medicine and Healthcare. Country Report Portugal. Paper presented at the EVIBASE State-of-the-Art Workshop Maastricht, February.Google Scholar
  26. Ollenschlaeger, G., Oesingmann, U., Thomeczek, C., Lampert, U. and Kolkmann, F.W. (1998) Leitlinien und Evidence-BasedMedicine in Deutschland (Guidelines and Evidence-Based Medicine in Germany). Muenchener Medizinische Wochenschrift 140(38), 502–505.Google Scholar
  27. Pientka, L. and Friedrich, C. (2000) Evidenz-basierte Medizin–Probleme und Anwendung in der Geriatrie (Evidence Based Medicine–Problems and Application in Geriatrics). Zeitschrift fuer Gerontologie und Geriatrie 33(2), 102–110.Google Scholar
  28. Raspe, H. (1996) Evidence based medicine: Modischer Unsinn, alter Wein in neuen Schlaeuchen oder aktuelle Notwendigkeit? (Evidence-Based Medicine: Popular Nonsense, Old Wine in New Bottles or Current Necessity?) Zeitschrift fuer aerztliche Fortbildung und Qualitaetssicherung 90(6), 553–562.Google Scholar
  29. Sepers, C. and Ter Meulen, R. (2001) Health Care and EBM in the Netherlands. Paper presented at the EVIBASE State-of-the-Art Workshop Maastricht, February.Google Scholar
  30. Vineis, P. and Ghisleni, M. (2001) Ethical Issues in Evidence Based Practice in Medical Care and Health Care. Country Report: Italy. Paper presented at the EVIBASE State-of-the-Art Workshop Maastricht, February.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Nikola Biller-Andorno
    • 1
  • Reidar K. Lie
    • 2
  • Ruud ter Meulen
    • 3
  1. 1.Department of Medical Ethics and History of MedicineUniversity of GoettingenGermany
  2. 2.Department of PhilosophyUniversity of BergenNorway
  3. 3.Institute for Bioethics, Department of Health Care EthicsUniversity of MaastrichtThe Netherlands

Personalised recommendations